87 related articles for article (PubMed ID: 22731503)
1. Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.
Tyagi S; Sharma S; Budhiraja RD
Can J Physiol Pharmacol; 2012 Jul; 90(7):881-5. PubMed ID: 22731503
[TBL] [Abstract][Full Text] [Related]
2. Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction.
Shah DI; Singh M
Int J Cardiol; 2007 Sep; 120(3):317-24. PubMed ID: 17240464
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
Shah DI; Singh M
Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602
[TBL] [Abstract][Full Text] [Related]
4. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
Kaur T; Goel RK; Balakumar P
Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
[TBL] [Abstract][Full Text] [Related]
5. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.
Balakumar P; Sharma R; Singh M
Pharmacol Res; 2008; 58(5-6):356-63. PubMed ID: 18951979
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B.
Sharma S; Singh M; Sharma PL
Eur J Pharmacol; 2013 Dec; 721(1-3):365-72. PubMed ID: 24021535
[TBL] [Abstract][Full Text] [Related]
7. Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats.
Shah DI; Singh M
Fundam Clin Pharmacol; 2006 Dec; 20(6):595-604. PubMed ID: 17109653
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of attenuation of diabetes mellitus and hypercholesterolemia induced vascular endothelial dysfunction by protein tyrosine phosphatase inhibition.
Sharma S; Singh M; Sharma PL
Vascul Pharmacol; 2011; 54(3-6):80-7. PubMed ID: 21237289
[TBL] [Abstract][Full Text] [Related]
9. Effect of fasudil on macrovascular disorder-induced endothelial dysfunction.
Shah DI; Singh M
Can J Physiol Pharmacol; 2006; 84(8-9):835-45. PubMed ID: 17111028
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of insulin in hyperhomocysteinemia and diabetes mellitus-induced vascular endothelium dysfunction: role of phosphoinositide dependent kinase and protein kinase B.
Sharma S; Singh M; Sharma PL
Mol Cell Biochem; 2011 Feb; 348(1-2):21-32. PubMed ID: 21069435
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
Shah DI; Singh M
Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in aortic rings and mesenteric beds isolated from deoxycorticosterone acetate hypertensive rats: possible involvement of protein kinase C.
Fatehi-Hassanabad Z; Fatehi M; Shahidi MI
Eur J Pharmacol; 2004 Jun; 494(2-3):199-204. PubMed ID: 15212975
[TBL] [Abstract][Full Text] [Related]
13. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.
Jyoti U; Kansal SK; Kumar P; Goyal S
Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):167-75. PubMed ID: 26497187
[TBL] [Abstract][Full Text] [Related]
14. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
Silambarasan T; Raja B
Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
17. Effect of bis(maltolato) oxovanadium on experimental vascular endothelial dysfunction.
Shah DI; Singh M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jun; 373(3):221-9. PubMed ID: 16736159
[TBL] [Abstract][Full Text] [Related]
18. Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats.
Sharma B; Singh N
Psychopharmacology (Berl); 2012 Oct; 223(3):307-17. PubMed ID: 22526544
[TBL] [Abstract][Full Text] [Related]
19. Uric acid does not affect the acetylcholine-induced relaxation of aorta from normotensive and deoxycorticosterone acetate-salt hypertensive rats.
Szasz T; Watts SW
J Pharmacol Exp Ther; 2010 Jun; 333(3):758-63. PubMed ID: 20215410
[TBL] [Abstract][Full Text] [Related]
20. How could aortic arginase activity enhancement be involved in DOCA-salt hypertension?
Rodriguez S; Schleiffer R; Raul F; Richert L; Berthelot A
Clin Exp Hypertens; 2004 Jan; 26(1):1-12. PubMed ID: 15000293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
